Roche Holding AG - Bearer Shares RO

SWX: RO | ISIN: CH0012032113   30/05/2025
280,00 CHF (+1,08%)
(+1,08%)   30/05/2025
Grafiek Roche Holding AG - Bearer Shares Grafiek Roche Holding AG - Bearer Shares

Roche Holding AG - Bearer Shares in het nieuws

30 mei 2025 · Roche’s fenebrutinib maintains near-complete suppression of disease activity and disability progression for up to two years in people with relapsing multiple sclerosis · Persbericht

23 mei 2025 · CHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer · Persbericht

23 mei 2025 · Roche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology · Persbericht

23 mei 2025 · New two-year follow-up of Roche’s Columvi extends overall survival in relapsed or refractory diffuse large B-cell lymphoma patients · Persbericht

22 mei 2025 · FDA approves Roche’s Susvimo for diabetic retinopathy · Persbericht

20 mei 2025 · Roche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma · Persbericht

14 mei 2025 · Roche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis · Persbericht

13 mei 2025 · Ten-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer · Persbericht

6 mei 2025 · Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity · Persbericht

30 april 2025 · CHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings · Persbericht

Profiel Roche Holding AG - Bearer Shares

CEO: Severin Schwan

Mijn selecties